Cystic Fibrosis Related Diabetes - An Update

Cystic fibrosis (CF) is the most common life-threatening inherited condition in the Caucasian population, where mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in a multifactorial syndrome, with pulmonary disease representing the largest contributor to morbidi...

Full description

Saved in:
Bibliographic Details
Published inQJM : An International Journal of Medicine Vol. 115; no. 9; pp. 582 - 585
Main Authors F, Frost, Mj, Walshaw, D, Nazareth
Format Journal Article
LanguageEnglish
Published England 22.09.2022
Subjects
Cystic Fibrosis Related Diabetes (CFRD)
Continuous Glucose Monitoring (CGM)
Diabetic Pulmonopathy
Online AccessGet full text

Cover

More Information
Summary:Cystic fibrosis (CF) is the most common life-threatening inherited condition in the Caucasian population, where mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in a multifactorial syndrome, with pulmonary disease representing the largest contributor to morbidity and mortality. Life expectancy has improved and the recent development of disease-modifying CFTR modulator therapies is likely to further improve survival. However, increasing life expectancy brings new challenges related to the complications of a chronic disease including an increasing prevalence of cystic fibrosis related diabetes (CFRD), itself associated with increased morbidity and early mortality. This review provides an update as regards the underlying mechanisms, investigation and management of CFRD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1460-2725
1460-2393
DOI:10.1093/qjmed/hcaa256